A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

January 31, 1998

Study Completion Date

January 31, 1998

Conditions

Healthy

Interventions

DRUG

Gabapentin 400 mg capsules

A: Experimental Subjects received Actavis formulated products under fasting conditions

DRUG

NEURONTIN® 400 mg capsules

B: Active comparator Subjects received Parke-Davis's marketed product

Trial Locations (1)

Gateway Medical Research, Inc, Saint Charles